Postdoctoral Fellowships FAQ
Information found here applies to all fellowships offered at the UNC Eshelman School of Pharmacy unless otherwise stated.
The Division of Pharmacotherapy and Experimental Therapeutics (DPET) offers industry-sponsored fellowships in Drug Development/Clinical Research, Global Drug Safety/Pharmacovigilance, Medical Affairs, and Regulatory Affairs. Fellows will spend time at GlaxoSmithKline, PPD, and United Therapeutics. Academic fellowships are offered in oncology. A clinical pharmacology fellowship is also available through the T32 Postdoctoral Training program.
The Division of Pharmaceutical Outcomes and Policy (DPOP) offers a two-year fellowship in Pharmaceutical Health Outcomes Research. This fellowship provides the training and experience needed to successfully compete for positions as a health outcomes researcher in academia, consulting, or in the pharmaceutical industry. Throughout the two years of this fellowship, fellows will receive training through didactic courses in research methods, statistics, pharmacoepidemiology, outcomes research, and pharmaceutical policy. In addition, fellows will spend time at GlaxoSmithKline in the US Health Outcomes Research Department working with health outcomes researchers on various health economics and outcomes research projects.
The Division of Practice Advancement and Clinical Education (PACE) offers an academic fellowship in educational development with the Pharmaceutical Care Lab. This academic fellowship helps promising professionals and scholars prepare for academic careers through postgraduate training in program development, teaching, scholarship, and practice.
More information about types of fellowships can be found here.
Yes. However, the GSK sponsored Global Regulatory Affairs fellowship requires relocation to the company’s Collegeville, Pennsylvania campus for the full two years of the fellowship.